The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

"Women coming off weight loss injections in midlife need to be particularly strategic about their approach," Rachael adds. "The hormonal shifts of midlife can reduce muscle protein synthesis by up to ...

A study found that medicines marketed as Zepbound and Mounjaro can help people lose weight for up to three years.

The India launch of Eli Lilly's Mounjaro in India has triggered a huge wave of enquiries from those looking for its ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

A STUDENT nurse is one step closer to her dream of having a baby after shedding 115lbs on Mounjaro. Laurie Murray, from Airdrie, started using the weight loss jabs last April when she tipped the ...

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...